TTALO cuts 2026 adjusted EBIT guidance to €110–120m as demand weakens
Weak demand reduced TTALO's third-quarter revenue and adjusted earnings, and the company lowered its FY 2026 EBIT outlook. Source: TradingView.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
According to TradingView, TTALO's revenue and adjusted earnings declined in the third quarter. The drop was driven by weak demand and lower activity in occupational health, which outweighed the impact of efficiency measures.
FY 2026 adjusted EBIT guidance was reduced to €110–120 million. The company expanded its Hohde oral health business, but leverage rose and the Silmäasema deal remains pending.
The source also says challenges are expected to continue in the fourth quarter.
why it matters
For investors, the key signal is the combination of lower earnings, a reduced outlook and higher leverage while a major acquisition is still pending. The share price will likely depend on how the fourth quarter unfolds and on progress with the Silmäasema transaction.
market impact
TTALO shares: weak demand and lower guidance pressure earnings expectations
tags
instruments
sources
- TTALO: Weak demand cut earnings; Hohde expanded oral health as FY guidance fell to €110–120m — TradingView, 21 October 2026 at 06:05 UTC
- TTALO: Weak demand cut Q3 earnings; Hohde expanded oral health as FY guidance remained cautious — TradingView, 21 October 2026 at 06:13 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗